Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Compared with various malignant tumors, lung cancer has high incidence and the highest mortality worldwide. Non-small-cell lung cancer (NSCLC), the most common kind of lung cancer, is still a great threat to the world, including China. Surgery, platinum-based chemotherapy, and radiotherapy are still...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei-Yun, Cui, Jia-Jia, Guo, Ao-Xiang, Yin, Ji-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790073/
https://www.ncbi.nlm.nih.gov/pubmed/29416353
http://dx.doi.org/10.2147/OTT.S136579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790073/
https://www.ncbi.nlm.nih.gov/pubmed/29416353
http://dx.doi.org/10.2147/OTT.S136579

Ejemplares similares